<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Albany Molecular Research Inc. | Company News & Executive Profiles - AMRI | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/albany+molecular+research+inc..html]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Albany Molecular Research Inc.]]></description>
	<s:counts start="0" returned="10" found="10" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Albany Molecular Research Q4 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-13071_23-267242.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Thank you. So the question-and-answer session will be conducted electronically. Operator Instructions. And we'll take our first question from Dave Windley of Jefferies & Company. David Windley - Jefferies & Company Hi. Good morning, gentlemen. Nice work on the quarter. Few questions here; on the GE Healthcare...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Mon, 09 Feb 2009 10:24:10 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/molecular+inc..html"><![CDATA[Molecular Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/jefferies+%2526+co..html"><![CDATA[Jefferies & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/albany+molecular+research+inc..html"><![CDATA[Albany Molecular Research Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMRI</category>
		<category domain="tickers">AMRI</category>
	</item>
	<item>
		<title><![CDATA[Albany Molecular Research, Inc. Q3 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-13071_23-250163.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator instructions. We'll take our first question from Dave Windley with Jefferies. David Windley &#8211; Jefferies & Co.  Hi, good morning. Thanks for taking the questions and congratulations on managing through tough environment here. Wondering on your BMS and access fee amortization and funded research, I...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Tue, 18 Nov 2008 03:37:11 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/revenue.html"><![CDATA[Revenue]]></category>
		<category domain="http://resources.bnet.com/topic/compound.html"><![CDATA[Compound]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/albany+molecular+research+inc..html"><![CDATA[Albany Molecular Research Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/operational+accounting.html"><![CDATA[Operational Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/revenue.html"><![CDATA[Revenue]]></category>
		<category domain="http://resources.bnet.com/topic/compound.html"><![CDATA[Compound]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/albany+molecular+research+inc..html"><![CDATA[Albany Molecular Research Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/operational+accounting.html"><![CDATA[Operational Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMRI</category>
		<category domain="tickers">AMRI</category>
	</item>
	<item>
		<title><![CDATA[Albany Molecular Research, Inc. Q2 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-13071_23-223606.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator  Operator instructions We will go first to Russ Silvestri and SKIRITAI Capital.  Russ Silverstri -- SKIRITAI Capital  Hi, congratulations. Actually I have four questions. One is Vyvanse being second sourced by anyone?  Mark Frost  Yes, this is Mark Frost, we are...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Sat, 30 Aug 2008 09:04:11 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/albany+molecular+research+inc..html"><![CDATA[Albany Molecular Research Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMRI</category>
		<category domain="tickers">AMRI</category>
	</item>
	<item>
		<title><![CDATA[Albany Molecular Research Inc. Q1 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-13071_23-227465.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Thank you. Operator Instructions And at this point Dr. D'Ambra, we have no questions. Thomas D'Ambra Thank you, Tamara. This concludes our conference call session for this morning. Thank you again, for your interest in AMRI. Operator And ladies and gentlemen that does conclude today's conference. We...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Mon, 05 May 2008 08:30:12 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/albany+molecular+research+inc..html"><![CDATA[Albany Molecular Research Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMRI</category>
		<category domain="tickers">AMRI</category>
	</item>
	<item>
		<title><![CDATA[Albany Molecular Research, Inc. Q4 2007 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-13071_23-230288.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator  Thank you.  Operator Instruction And we&#39;ll take our first question from Amy Stevens with Susquehanna Financial. Amy Stevens  Yes, good morning guys. Thanks for taking the question. I just wanted to follow-up a little bit on the DEA quota situation with regard to Vyvanse...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Mon, 11 Feb 2008 10:01:07 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/albany+molecular+research+inc..html"><![CDATA[Albany Molecular Research Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMRI</category>
		<category domain="tickers">AMRI</category>
	</item>
	<item>
		<title><![CDATA[Albany Molecular Research, Inc. Announces Fourth Quarter, Full Year 2005 Results; Posts Full Year Contract Revenue Growth of 13%]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_Feb_13/ai_n16061911]]></link>
		<description><![CDATA[ALBANY, N.Y. -- Albany Molecular Research, Inc. (Nasdaq: AMRI) today reported financial results for the quarter and year ending December 31, 2005.]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 13 Feb 2006 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/ge+healthcare.html"><![CDATA[GE Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/bristol-myers+squibb+co..html"><![CDATA[Bristol-Myers Squibb Co.]]></category>
		<category domain="http://resources.bnet.com/topic/albany+molecular+research+inc..html"><![CDATA[Albany Molecular Research Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/amri.html"><![CDATA[AMRI]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMRI</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
		<category domain="tickers">AMRI,BMY</category>
	</item>
	<item>
		<title><![CDATA[Albany Molecular Research, Inc. to Fund Postdoctoral Fellowships at Rensselaer Polytechnic Institute and University at Albany]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2002_April_26/ai_85084963]]></link>
		<description><![CDATA[Business Editors  ALBANY, N.Y.--BUSINESS WIRE--April 26, 2002  Albany Molecular Research, Inc. (Nasdaq: AMRI) announced today that it has awarded funding for a postdoctoral research associate position to two universities in the Capital District.  The awards--which together total over $100,000 per year--are to recognize support from each institution...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 26 Apr 2002 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/albany.html"><![CDATA[Albany]]></category>
		<category domain="http://resources.bnet.com/topic/albany+molecular+research+inc..html"><![CDATA[Albany Molecular Research Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/career.html"><![CDATA[CAREER]]></category>
		<category domain="http://resources.bnet.com/topic/chemistry.html"><![CDATA[chemistry]]></category>
		<category domain="http://resources.bnet.com/topic/dr..html"><![CDATA[Dr.]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/institute.html"><![CDATA[Institute]]></category>
		<category domain="http://resources.bnet.com/topic/professor.html"><![CDATA[professor]]></category>
		<category domain="http://resources.bnet.com/topic/rensselaer+polytechnic+institute.html"><![CDATA[Rensselaer Polytechnic Institute]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMRI</category>
		<category domain="tickers">AMRI</category>
	</item>
	<item>
		<title><![CDATA[Albany Molecular Research, Inc. Contributes to Disaster Relief Funds]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2001_Sept_21/ai_78478508]]></link>
		<description><![CDATA[Business Editors  ALBANY, N.Y.--BUSINESS WIRE--Sept. 21, 2001  Albany Molecular Research, Inc. (Nasdaq: AMRI) and its employees have donated a total of $120,000 to help those impacted by the September 11 tragedies.  Additionally, the company has donated, through the Albany County Emergency Management Office, respirators to the emergency...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 21 Sep 2001 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/albany+molecular+research+inc..html"><![CDATA[Albany Molecular Research Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/tragedy.html"><![CDATA[tragedy]]></category>
		<category domain="http://resources.bnet.com/topic/world+trade+center.html"><![CDATA[World Trade Center]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMRI</category>
		<category domain="tickers">AMRI</category>
	</item>
	<item>
		<title><![CDATA[Albany Molecular Research, Inc. Completes Acquisition of EnzyMed, Inc]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_1999_Oct_20/ai_56641933]]></link>
		<description><![CDATA[ALBANY, N.Y.--BUSINESS WIRE--Oct. 20, 1999--  Albany Molecular Research, Inc. (NASDAQ: AMRI) announced today that it has successfully completed the previously announced acquisition of EnzyMed, Inc. EnzyMed will retain its corporate identity as an independent business unit, continuing to develop and market its combinatorial biocatalysis platform for drug discovery technology...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 20 Oct 1999 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/acquisition.html"><![CDATA[acquisition]]></category>
		<category domain="http://resources.bnet.com/topic/albany.html"><![CDATA[Albany]]></category>
		<category domain="http://resources.bnet.com/topic/albany+molecular+research+inc..html"><![CDATA[Albany Molecular Research Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/business+wire.html"><![CDATA[Business Wire]]></category>
		<category domain="http://resources.bnet.com/topic/chemistry.html"><![CDATA[chemistry]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/outsourcing.html"><![CDATA[Outsourcing]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMRI</category>
		<category domain="tickers">AMRI</category>
	</item>
	<item>
		<title><![CDATA[Albany Molecular Research, Inc. Renews and Expands Research Collaboration with Purdue Pharma in Contract Valued at $1 Million]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_1999_Oct_20/ai_56647407]]></link>
		<description><![CDATA[ALBANY, N.Y.--BUSINESS WIRE--October 20, 1999--  Albany Molecular Research, Inc. (NASDAQ: AMRI) announced today that Norwalk, Connecticut-based pharmaceutical company Purdue Pharma L.P. has renewed and expanded its research collaboration with the Albany firm. The research contract, valued at approximately $1 million, calls for AMRI chemical scientists to work full time...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 20 Oct 1999 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/albany+molecular+research+inc..html"><![CDATA[Albany Molecular Research Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/purdue+pharma+l.p..html"><![CDATA[Purdue Pharma L.P.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMRI</category>
		<category domain="tickers">AMRI</category>
	</item>
</channel>
</rss>
